Dollar General Q4 EPS $2.96, net sales $10.2B; same-store sales +5.7%; guides FY2023 EPS growth 4-6%

DOLLAR GENERAL CORP

2022-FY EPS reported $10.68 revenue$37,844,863,000

Diluted EPS $2.96 vs $2.57 in Q4 2021 (+15.2%); net income $659.1M (+10.3%).
Net sales $10.2B (+17.9%) including 53rd week; same-store sales +5.7% driven by higher average transaction.
FY2023 guidance: net sales growth ~5.5-6%, same-store sales +3.0-3.5%, diluted EPS growth 4-6%.
Board declares increased quarterly dividend of $0.59/share (payable Apr 25 to record Apr 11).
FY2022 share repurchases $2.7B; plans $500M in FY2023; capex $1.8-1.9B with ~3,170 real estate projects.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DOLLAR GENERAL CORP reported the fiscal 2022 fourth quarter (14 weeks) and full year (53 weeks) ended February 3, 2023 results: revenue $10.2 billion, net income $659.1 million, EPS $2.96. Guidance reaffirmed.

Period: the fiscal 2022 fourth quarter (14 weeks) and full year (53 weeks) ended February 3, 2023
Revenue: $10.2 billion
Net income: $659.1 million
EPS: $2.96
Guidance: reaffirmed
Result: reported results

Exact text from the filing

will yield strong returns as we continue creating long-term sustainable growth and value for our shareholders.” Fourth Quarter 2022 Highlights Net sales increased 17.9% to $10.2 billion in the fourth quarter of 2022 compared to $8.7 billion in the fourth quarter of 2021. Net sales for the 53 rd week of fiscal 2022 were $678.1 million. The net sales increase was

View on SEC.gov

23 earnings releases filed in the last 30 days. Browse all earnings releases →

DOLLAR GENERAL CORP filing history →

Source: SEC EDGAR

accession 0001157523-23-000445

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.